These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37048068)

  • 1. Development of a Triple-Negative Breast Cancer Leptomeningeal Disease Model in Zebrafish.
    Gopal U; Monroe JD; Marudamuthu AS; Begum S; Walters BJ; Stewart RA; Washington CW; Gibert Y; Zachariah MA
    Cells; 2023 Mar; 12(7):. PubMed ID: 37048068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fangjihuangqi Decoction inhibits MDA-MB-231 cell invasion in vitro and decreases tumor growth and metastasis in triple-negative breast cancer xenografts tumor zebrafish model.
    Guo Y; Fan Y; Pei X
    Cancer Med; 2020 Apr; 9(7):2564-2578. PubMed ID: 32037729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing chemosensitivity of wild-type and drug-resistant MDA-MB-231 triple-negative breast cancer cell line to doxorubicin by silencing of STAT 3, Notch-1, and β-catenin genes.
    Alkaraki A; Alshaer W; Wehaibi S; Gharaibeh L; Abuarqoub D; Alqudah DA; Al-Azzawi H; Zureigat H; Souleiman M; Awidi A
    Breast Cancer; 2020 Sep; 27(5):989-998. PubMed ID: 32328816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic effect of anethole and doxorubicin alleviates cell proliferation, cell cycle arrest, and ER stress and promotes ROS-mediated apoptosis in triple-negative breast cancer cells.
    Arumugam P; Sampathkumar B; Perumalsamy H; Balusamy SR; Ramesh V; Sundaravadevel S
    J Biochem Mol Toxicol; 2021 Dec; 35(12):e22928. PubMed ID: 34585488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic Effect of SH003 and Doxorubicin in Triple-negative Breast Cancer.
    Woo SM; Kim AJ; Choi YK; Shin YC; Cho SG; Ko SG
    Phytother Res; 2016 Nov; 30(11):1817-1823. PubMed ID: 27476488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pivarubicin Is More Effective Than Doxorubicin Against Triple-Negative Breast Cancer In Vivo.
    Lothstein L; Soberman J; Parke D; Gandhi J; Sweatman T; Seagroves T
    Oncol Res; 2020 Dec; 28(5):451-465. PubMed ID: 32430093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of proton pump inhibitors as adjunct treatment for triple-negative breast cancers. An introductory study.
    Goh W; Sleptsova-Freidrich I; Petrovic N
    J Pharm Pharm Sci; 2014; 17(3):439-46. PubMed ID: 25224353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulforaphane induces autophagy by inhibition of HDAC6-mediated PTEN activation in triple negative breast cancer cells.
    Yang F; Wang F; Liu Y; Wang S; Li X; Huang Y; Xia Y; Cao C
    Life Sci; 2018 Nov; 213():149-157. PubMed ID: 30352240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [10]-Gingerol improves doxorubicin anticancer activity and decreases its side effects in triple negative breast cancer models.
    Baptista Moreno Martin AC; Tomasin R; Luna-Dulcey L; Graminha AE; Araújo Naves M; Teles RHG; da Silva VD; da Silva JA; Vieira PC; Annabi B; Cominetti MR
    Cell Oncol (Dordr); 2020 Oct; 43(5):915-929. PubMed ID: 32761561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical Evaluation of a Novel Orally Available SRC/Raf/VEGFR2 Inhibitor, SKLB646, in the Treatment of Triple-Negative Breast Cancer.
    Zheng MW; Zhang CH; Chen K; Huang M; Li YP; Lin WT; Zhang RJ; Zhong L; Xiang R; Li LL; Liu XY; Wei YQ; Yang SY
    Mol Cancer Ther; 2016 Mar; 15(3):366-78. PubMed ID: 26721945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzalutamide Overcomes Dihydrotestosterone-Induced Chemoresistance in Triple- Negative Breast Cancer Cells
    Alsawalha L; Ahram M; Abdullah MS; Dalmizrak O
    Anticancer Agents Med Chem; 2022; 22(17):3038-3048. PubMed ID: 35579133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LLY17, a novel small molecule STAT3 inhibitor induces apoptosis and suppresses cell migration and tumor growth in triple-negative breast cancer.
    Pan L; Chen X; Fu S; Yu W; Li C; Wang T; Lo HW; Lin J
    Breast Cancer Res Treat; 2020 May; 181(1):31-41. PubMed ID: 32240456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diterpenoid natural compound C4 (Crassin) exerts cytostatic effects on triple-negative breast cancer cells via a pathway involving reactive oxygen species.
    Richards CE; Vellanki SH; Smith YE; Hopkins AM
    Cell Oncol (Dordr); 2018 Feb; 41(1):35-46. PubMed ID: 29134467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Brain-Permeant Chemotherapeutic Agent for the Treatment of Brain Metastasis in Triple-Negative Breast Cancer.
    Deng J; Chernikova SB; Wang Y; Rodriguez ML; Andersen SJ; Umeh-Garcia MC; Godfrey BO; Ahmadian SS; Fischer WN; Koller KJ; Jandeleit B; Ringold GM; Gephart MH
    Mol Cancer Ther; 2021 Nov; 20(11):2110-2116. PubMed ID: 34635566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of aerobic glycolysis enhances the anti-tumor efficacy of Zoptarelin Doxorubicin in triple-negative breast cancer cells.
    Gründker C; Wokoun U; Hellriegel M; Emons G
    J Obstet Gynaecol Res; 2019 Jul; 45(7):1334-1342. PubMed ID: 31016845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulating GRP78 reverses pirarubicin resistance of triple negative breast cancer by miR-495-3p mimics and involves the p-AKT/mTOR pathway.
    Liu M; Yang J; Lv W; Wang S; Du T; Zhang K; Wu Y; Feng X
    Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 34935899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic effect of photodynamic treatment and doxorubicin on triple negative breast cancer cells.
    Yousefi Sadeghloo A; Khorsandi K; Kianmehr Z
    Photochem Photobiol Sci; 2020 Nov; 19(11):1580-1589. PubMed ID: 33030191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of HJ-PI01 as a novel Pim-2 inhibitor that induces apoptosis and autophagic cell death in triple-negative human breast cancer.
    Zhao YQ; Yin YQ; Liu J; Wang GH; Huang J; Zhu LJ; Wang JH
    Acta Pharmacol Sin; 2016 Sep; 37(9):1237-50. PubMed ID: 27397540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced cytotoxic activity of doxorubicin through the inhibition of autophagy in triple negative breast cancer cell line.
    Aydinlik S; Erkisa M; Cevatemre B; Sarimahmut M; Dere E; Ari F; Ulukaya E
    Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):49-57. PubMed ID: 27842219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual-targeted hybrid nanoparticles of synergistic drugs for treating lung metastases of triple negative breast cancer in mice.
    Zhang T; Prasad P; Cai P; He C; Shan D; Rauth AM; Wu XY
    Acta Pharmacol Sin; 2017 Jun; 38(6):835-847. PubMed ID: 28216624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.